CorVel Corporation
CRVL
주식 순위
#4002
CorVel Corporation delivers comprehensive solutions designed to assist... CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
주가
$81.14
마지막 동기화: 2026-10-20
시가총액
$4.10B
변동 (1일)
1.79%
변동 (1년)
6.25%
국가
US
거래 CorVel Corporation (CRVL)
카테고리
Financial Services
CorVel Corporation (CRVL)의 발행 주식 수
June 2026 기준 발행 주식 수: 50.80M
CorVel Corporation의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 50.80M입니다. March 2024 말 기준 회사는 51.37M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
CorVel Corporation (CRVL)의 발행 주식 수 기록 (2000 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 50.80M | -1.14% |
| 2025 | 51.39M | 0.04% |
| 2024 | 51.37M | -1.19% |
| 2023 | 51.98M | -2.39% |
| 2022 | 53.26M | -0.99% |
| 2021 | 53.79M | -2.16% |
| 2020 | 54.98M | -2.49% |
| 2019 | 56.38M | -0.16% |
| 2018 | 56.48M | -3.05% |
| 2017 | 58.25M | -3.34% |
| 2016 | 60.27M | 0.00% |
| 2015 | 60.27M | -4.80% |
| 2014 | 63.31M | -13.73% |
| 2013 | 73.39M | 0.00% |
| 2012 | 73.39M | 0.00% |
| 2011 | 73.39M | 0.00% |
| 2010 | 73.39M | 0.00% |
| 2009 | 73.39M | -11.73% |
| 2008 | 83.14M | -1.52% |
| 2007 | 84.42M | -3.19% |
| 2006 | 87.20M | -7.01% |
| 2005 | 93.77M | -1.54% |
| 2004 | 95.24M | -0.83% |
| 2003 | 96.04M | -3.37% |
| 2002 | 99.39M | -3.12% |
| 2001 | 102.59M | -5.26% |
| 2000 | 108.28M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 482.00M | 848.74% |
US
|
|
| 256.65M | 405.17% |
US
|
|
| 213.80M | 320.83% |
IE
|
|
| - | - |
GB
|
|
| - | - |
US
|
